U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process (Drugs)
  4. CDER Small Business & Industry Assistance (SBIA)
  5. FDA Small Business Regulatory Education for Industry (REdI): Generic Drugs Forum 2016
  1. Development & Approval Process (Drugs)

FDA Small Business Regulatory Education for Industry (REdI): Generic Drugs Forum 2016

FDA Small Business Regulatory Education for Industry (REdI): Generic Drugs Forum 2016

For slides from this event, click heredisclaimer icon

image of CDER SBIA April 2016 REdI

 
This two-day FDA-led forum offered you the opportunity to interact with FDA subject matter experts as we discussed various topics along the dynamic continuum of the generic drug approval process.
 
Keynote Speaker: Kathleen Uhl, M.D. Director, Office of Generic Drugs, CDER, FDA
 
Topics include:
  • Communication with Industry
  • Current Trends in Labeling and Best Practices
  • GDUFA Regulatory Science
 

For more information on

(866)-405-5367 | (301)-796-6707 | CDER Small Business and Industry Assistance CDERSBIA@fda.hhs.gov